Las Vegas, NV -- (SBWIRE) -- 01/28/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Exelixis, Inc. (NASDAQ:EXEL), Electronic Arts Inc. (NASDAQ:EA), Idera Pharmaceuticals Inc (NASDAQ:IDRA), Molycorp Inc (NYSE:MCP).
Exelixis, Inc. (NASDAQ:EXEL) ended its recent business day with the tumbled of -7.07% and closed at the price of $7.10 after opening at $7.61. The stock traded during its last trading session with the total volume of 6.00 million shares, as compared to its average volume of 3.17 million shares. Exelixis, Inc., a biotechnology company, engages in developing small molecule therapies for the treatment of cancer in the United States.
Has EXEL Found The Bottom And Ready To Gain Momentum? Find Out Here
Electronic Arts Inc. (NASDAQ:EA) remained among the day bullish 2.64% and traded with volume of 8.22 million shares in the last session, as compared to average volume of 5.34 million shares. In comparison with 52 week range of $14.31 - $28.13, it faced lowest price of $23.73 during the last trading session whereas its day highest price was $24.58. The company’s total market capitalization is $7.56 billion, along with 309.12 million shares outstanding. Electronic Arts Inc. develops, markets, publishes, and distributes game software content and services for video game consoles, personal computers, mobile phones, tablets and electronic readers, and the Internet.
Will EA Continue To Move Higher? Find out via this report
Idera Pharmaceuticals Inc (NASDAQ:IDRA) showed 2.16 million shares in volume during the last trading session, while the average trading volume remained 2.83 million shares. The stock kicked off its trading session at $4.03 and closed at $3.71 after dropped -7.71%. Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, engages in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.
Will IDRA Get Buyers Even After The Recent Rally? Find Out Here
Molycorp Inc (NYSE:MCP) stock traded during its last trading session with the total traded volume of 5.81 million shares versus its average volume of 8.64 million shares. The company opened its trade at the price of $4.98 and its closing price was $4.84 after fell -3.39% for the day. Molycorp, Inc. produces and sells rare earth and rare metal materials in the United States and internationally.
Has MCP Found The Bottom and Ready To Move Up? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)